Table 3.

Triptan-related adverse events

	DFN-11 (n  =  111) n (%)	Placebo (n  =  119) n (%)	Total (N  =  230) n (%)
Subjects with ≥1 triptan-related AE	8 (7.2)	3 (2.5)	11 (4.8)
Palpitations	0 (0.0)	1 (0.8)	1 (0.4)
Nausea	2 (1.8)	0 (0.0)	2 (0.9)
Chest discomfort	1 (0.9)	2 (1.7)	3 (1.3)
Dizziness	1 (0.9)	0 (0.0)	1 (0.4)
Lethargy	1 (0.9)	0 (0.0)	1 (0.4)
Paresthesia	3 (2.7)	0 (0.0)	3 (1.3)
Dyspnea	0 (0.0)	1 (0.8)	1 (0.4)
Throat irritation	1 (0.9)	0 (0.0)	1 (0.4)
Throat tightness	2 (1.8)	0 (0.0)	2 (0.9)

AE, adverse event